These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2273104)

  • 1. Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease.
    Kaufman LD; Seidman RJ; Phillips ME; Gruber BL
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1063-9. PubMed ID: 2273104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic features of the L-tryptophan-related eosinophilia-myalgia (fasciitis) syndrome.
    Winkelmann RK; Connolly SM; Quimby SR; Griffing WL; Lie JT
    Mayo Clin Proc; 1991 May; 66(5):457-63. PubMed ID: 1709432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome.
    Bulpitt KJ; Verity MA; Clements PJ; Paulus HE
    Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papular mucinosis in L-tryptophan-induced eosinophilia-myalgia syndrome.
    Valicenti JM; Fleming MG; Pearson RW; Budz JP; Gendleman MD
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):54-8. PubMed ID: 1880255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.
    Varga J; Peltonen J; Uitto J; Jimenez S
    Ann Intern Med; 1990 Mar; 112(5):344-51. PubMed ID: 2306063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [L-tryptophan-induced eosinophilia-myalgia syndrome with features of diffuse fasciitis with eosinophilia].
    Senff H; Köllner A; Engelmann L; Woort-Menker M; Mensing H; Kunze J
    Hautarzt; 1990 Oct; 41(10):578-82. PubMed ID: 2258302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia-myalgia syndrome.
    Troy JL
    Mayo Clin Proc; 1991 May; 66(5):535-8. PubMed ID: 2030620
    [No Abstract]   [Full Text] [Related]  

  • 8. L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.
    Freundlich B; Werth VP; Rook AH; O'Connor CR; Schumacher HR; Leyden JJ; Stolley PD
    Ann Intern Med; 1990 May; 112(10):758-62. PubMed ID: 2331120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.
    Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ
    Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM
    N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
    Blauvelt A; Falanga V
    Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
    Verity MA; Bulpitt KJ; Paulus HE
    Hum Pathol; 1991 Jan; 22(1):3-11. PubMed ID: 1985074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic fasciitis associated with L-tryptophan ingestion.
    Grigoris I; de Launey W; Jevtic AP
    Med J Aust; 1992 Sep; 157(5):329-30. PubMed ID: 1435477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
    Beko E; Pervaiz S; Nanda V; Dhawan S
    Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-tryptophan induced eosinophilia-myalgia syndrome.
    Chartash EK; Given WP; Vishnubhakat SM; Susin M; Coffey EL; Farmer PM; Albanese JM; Kaplan MH; Furie RA
    J Rheumatol; 1990 Nov; 17(11):1527-33. PubMed ID: 2273498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma and L-tryptophan: a possible explanation of the eosinophilia-myalgia syndrome.
    Connolly SM; Quimby SR; Griffing WL; Winkelmann RK
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):451-7. PubMed ID: 2212143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity?
    Clauw DJ; Nashel DJ; Umhau A; Katz P
    JAMA; 1990 Mar; 263(11):1502-6. PubMed ID: 2308182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic fasciitis associated with the eosinophilia-myalgia syndrome.
    Jaffe I; Kopelman R; Baird R; Grossman M; Hays A
    Am J Med; 1990 May; 88(5):542-6. PubMed ID: 2337110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.